BAM
IMGN

Berkshire Asset Management’s Immunogen Inc IMGN Stock Holding History

Berkshire Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,773
Closed -$51K – 238
2022
Q1 		$51K Sell
10,773
-161
-1% -$891 ﹤0.01% 201
2021
Q4 		$81K Sell
10,934
-622
-5% -$3.87K ﹤0.01% 238
2021
Q3 		$66K Sell
11,556
-163
-1% -$942 ﹤0.01% 238
2021
Q2 		$77K Buy
11,719
+163
+1% +$1.14K 0.01% 232
2021
Q1 		$94K Sell
11,556
-841
-7% -$6.87K 0.01% 225
2020
Q4 		$80K Buy
+12,397
New +$72.3K 0.01% 218
2020
Q2 		– Sell
-11,862
Closed -$40K – 199
2020
Q1 		$40K Buy
+11,862
New +$51.9K ﹤0.01% 200

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Berkshire Asset Management's IMGN Position: Q2 2022 in Review

Berkshire Asset Management sold out of Immunogen Inc (IMGN) in Q2 2022, closing a stake of 10,773 shares — an estimated $51K sold.

Berkshire Asset Management first reported a position in IMGN in Q1 2020 and held it in 7 quarters. The position peaked at $94K in Q1 2021. 216 funds tracked by Wall St. Rank hold IMGN as of Q2 2022.

  • Berkshire Asset Management reported no remaining Immunogen Inc position as of Q2 2022 after selling out during the quarter.
  • Berkshire Asset Management sold 10,773 Immunogen Inc shares in Q2 2022, an estimated $51K.
  • Berkshire Asset Management first reported a position in Immunogen Inc in Q1 2020 and held it in 7 quarters.
  • Berkshire Asset Management's Immunogen Inc position peaked at $94K in Q1 2021.
  • 216 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2022.

Based on Berkshire Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.